What is your preferred front line regimen for metastatic squamous cell NSCLC that is PD-L1 and driver mutation negative?

I believe each are acceptable options. I have generally been using carboplatin and weekly paclitaxel fairly commonly. This regimen is based on Quoix, et al Lancet trial. This study was in elderly patients. I find this very well tolerated with low chances of cytopenias, alopecia. If I have concerns a...